Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 11, 2017 06:30 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Presenting New LIMITx™ Clinical Data at the 19th Annual Rodman & Renshaw Conference

PALATINE, Ill., Sept. 11, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced the results from the...
August 31, 2017 06:00 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals to Present at the 19th Annual RODMAN & RENSHAW Conference

PALATINE, Ill., Aug. 31, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that Bob Jones,...
August 14, 2017 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces Second Quarter 2017 Financial Results

PALATINE, Ill., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for...
August 03, 2017 06:00 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals to Host Second Quarter 2017 Financial Results Conference Call on August 15, 2017

PALATINE, Ill., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the Company...
July 24, 2017 16:42 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Raises $4.0 Million in a Private Placement

PALATINE, Ill., July 24, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that it has completed...
June 28, 2017 16:10 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Advances LTX-04 and its LIMITx™ Technology

PALATINE, Ill., June 28, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the results from...
May 18, 2017 16:10 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceutical Initiates Second Clinical Study on LTX-04

PALATINE, Ill., May 18, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the Company has...
May 12, 2017 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces First Quarter 2017 Financial Results

PALATINE, Ill., May 12, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial...
March 31, 2017 16:01 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces Fourth Quarter 2016 and Full Year 2016 Financial Results

PALATINE, Ill., March 31, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial...
March 17, 2017 06:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals and MainPointe Pharmaceuticals Announce Deal for Nexafed® Products

PALATINE, Ill., March 17, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR) and MainPointe Pharmaceuticals, LLC today announced that they have entered into a License Agreement (the...